FDA Releases Draft Guidance on Assessing Growth, Puberty in Pediatric Trials
November 30, 2022
Trials of drugs for pediatric use should train clinical investigators and trial staff to measure and evaluate the drug’s potential impact on participants’ physical growth and sexual development, according to recent FDA draft guidance.